An in-depth look to CHI SHENG PHARMA & BIOTECH CO LTD operating, investing, and financing activities

4111 free cash flow for Q3 24 is -20.54 M TWD. For 2023, 4111 free cash flow was -32.77 M TWD and operating cash flow was 68.73 M TWD.